MA H4956

Prohibits health insurers from refusing to pay participating providers for covered clinician-administered drugs or imposing higher copays, coinsurance, or penalties when patients obtain these drugs from their chosen provider or pharmacy

Bars insurers from steering patients to specific pharmacies through inducements, financial incentives, or requirements to use insurer-selected pharmacies for clinician-administered drugs

Requires equal reimbursement rates for clinician-administered drugs regardless of which pharmacy dispenses them, preventing reduced payments for non-preferred pharmacies

Prohibits insurers from requiring specialty pharmacies to dispense medications directly to patients for transport to healthcare providers for administration

Allows but does not mandate insurers to offer home infusion pharmacy services or external infusion sites as alternatives to provider office administration